Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis
Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients; however, controversy exists as to whether mortality in serious infections can be decreased through administration by prolonged infusion compared with intermittent infusion. The purpose of this systematic...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English English English |
| Published: |
The Society of Critical Care Medicine and Wolters Kluwer Health, Inc.
2018
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/59246/ http://irep.iium.edu.my/59246/ http://irep.iium.edu.my/59246/ http://irep.iium.edu.my/59246/1/59246_Prolonged%20infusion%20piperacillin-tazobactam.pdf http://irep.iium.edu.my/59246/2/59246_Prolonged%20infusion%20piperacillin-tazobactam_WOS.pdf http://irep.iium.edu.my/59246/13/59246_Prolonged%20infusion%20piperacillin-tazobactam%20decreases%20mortality%20and%20improves_SCOPUS.pdf |
Internet
http://irep.iium.edu.my/59246/http://irep.iium.edu.my/59246/
http://irep.iium.edu.my/59246/
http://irep.iium.edu.my/59246/1/59246_Prolonged%20infusion%20piperacillin-tazobactam.pdf
http://irep.iium.edu.my/59246/2/59246_Prolonged%20infusion%20piperacillin-tazobactam_WOS.pdf
http://irep.iium.edu.my/59246/13/59246_Prolonged%20infusion%20piperacillin-tazobactam%20decreases%20mortality%20and%20improves_SCOPUS.pdf